| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.04 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.097 | 0.04 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.091 | 0.04 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.04 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.04 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.04 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |